Pembrolizumab-Induced Severe Neuropathy in a Patient with Metastatic Urothelial Carcinoma after Achieving Complete Response: Guillain-Barré Syndrome-Like Onset.

Aoki, Shuntaro; Yasui, Masato; Tajirika, Hironao; Terao, Hideyuki; Funahashi, Makoto; Ohta, Junichi

Aoki, Shuntaro; Yasui, Masato; Tajirika, Hironao; Terao, Hideyuki; Funahashi, Makoto; Ohta, Junichi.

Afiliación

Aoki S; Department of Urology, Yokohama Municipal Citizen's Hospital, Yokohama, Japan.
Yasui M; Department of Urology and Renal Transplantation, Yokohama City University Medical Center, Yokohama, Japan.
Tajirika H; Department of Urology, Yokohama Municipal Citizen's Hospital, Yokohama, Japan.
Terao H; Department of Urology and Renal Transplantation, Yokohama City University Medical Center, Yokohama, Japan.
Funahashi M; Department of Urology, Yokohama Municipal Citizen's Hospital, Yokohama, Japan.
Ohta J; Department of Urology, Yokohama Municipal Citizen's Hospital, Yokohama, Japan.

Case Rep Oncol ; 13(3): 1490-1494, 2020.

Article en En | MEDLINE | ID: mdl-33564288

Palabras clave

Guillain-Barré syndrome; Methylprednisolone; Pembrolizumab; Peripheral neuropathy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Case Rep Oncol Año: 2020 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google